Author:
Focosi Daniele,Franchini Massimo,Senefeld Jonathon W.,Casadevall Arturo,Joyner Michael J.
Subject
Infectious Diseases,Virology
Reference13 articles.
1. S Cesaro, P Ljungman, M Mikulska, HH Hirsch, M von Lilienfeld-Toal, C Cordonnier, S Meylan, V Mehra, J Styczynski, F Marchesi, C Besson, F Baldanti, R Cordoba Masculano, G Beutel, H Einsele, E Azoulay, J Maertens, R de la Camara, ECIL 9; L Pagano. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022 Jun;36(6):1467-1480. doi: 10.1038/s41375-022-01578-1. Epub 2022 Apr 29.
2. FDA updates Sotrovimab emergency use authorization. March 30, 2022. Accessed online at https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-sotrovimab-emergency-use-authorization on April 26, 2022.
3. FDA authorizes revisions to Evusheld dosing. Accessed online on April 29, 2022 at https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-evusheld-dosing.
4. Benotmane I, Velay A, Vargas GG, Olagne J, Fafi-Kremer S, Thaunat O, et al. Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients. 2022:2022.03.19.22272575.
5. Resistance mutations in SARS-CoV-2 Delta variant after sotrovimab use;Rockett;N. Engl. J. Med.,2021
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献